Latest filing published 12 Oct 2007 for MAP Pharmaceuticals, Inc., €1.8M.
Insider track record
No signal scores available.
Bay City Capital Fund IV, L.P.: trading record in brief
Bay City Capital Fund IV, L.P. is a declared insider of MAP Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 11 October 2007 to 11 March 2010.
The open-market record consists of 3 sales worth €3.9M, with no purchase. So far in 2010, the count stands at no purchases and 3 sales.
The record was last updated on 11 March 2010 with an open-market sale (€1.6M) in MAP Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bay City Capital Fund IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 176,470 shares@ US$14.50Common StockSEC:0001181431-07-062032:0
- 2,170,607 shares@ US$14.50Common StockSEC:0001181431-07-062032:1
2 of 2 declarations
